Nuveen Asset Management LLC Sells 11,939 Shares of BrightSpring Health Services, Inc. (NASDAQ:BTSG)

Nuveen Asset Management LLC decreased its stake in BrightSpring Health Services, Inc. (NASDAQ:BTSG - Free Report) by 0.7% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,673,093 shares of the company's stock after selling 11,939 shares during the period. Nuveen Asset Management LLC owned about 0.96% of BrightSpring Health Services worth $28,493,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in BTSG. FMR LLC lifted its stake in BrightSpring Health Services by 21.6% in the 4th quarter. FMR LLC now owns 22,102,490 shares of the company's stock valued at $376,405,000 after purchasing an additional 3,933,303 shares during the last quarter. T. Rowe Price Investment Management Inc. bought a new position in BrightSpring Health Services in the 4th quarter valued at approximately $26,958,000. Norges Bank bought a new position in BrightSpring Health Services in the 4th quarter valued at approximately $26,065,000. Raymond James Financial Inc. bought a new position in BrightSpring Health Services in the 4th quarter valued at approximately $18,257,000. Finally, Integral Health Asset Management LLC lifted its stake in BrightSpring Health Services by 90.0% in the 4th quarter. Integral Health Asset Management LLC now owns 950,000 shares of the company's stock valued at $16,178,000 after purchasing an additional 450,000 shares during the last quarter.

Wall Street Analyst Weigh In

Several equities analysts have recently issued reports on BTSG shares. UBS Group raised their price target on shares of BrightSpring Health Services from $22.00 to $30.00 and gave the company a "buy" rating in a research note on Wednesday, January 29th. Mizuho set a $26.00 price target on shares of BrightSpring Health Services in a research note on Monday, May 5th. Morgan Stanley raised their price target on shares of BrightSpring Health Services from $20.00 to $25.00 and gave the company an "overweight" rating in a research note on Friday, May 9th. Finally, Wells Fargo & Company raised their price target on shares of BrightSpring Health Services from $25.00 to $27.00 and gave the company an "overweight" rating in a research note on Tuesday, May 13th. One analyst has rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.56.

BrightSpring Health Services Trading Up 0.6%

NASDAQ BTSG traded up $0.15 during mid-day trading on Tuesday, reaching $23.38. 1,330,026 shares of the stock were exchanged, compared to its average volume of 1,430,886. BrightSpring Health Services, Inc. has a one year low of $10.15 and a one year high of $24.82. The stock has a 50 day simple moving average of $19.41 and a 200-day simple moving average of $19.28. The stock has a market cap of $4.07 billion, a P/E ratio of -89.92 and a beta of 2.06. The company has a debt-to-equity ratio of 1.63, a current ratio of 1.35 and a quick ratio of 0.97.

BrightSpring Health Services (NASDAQ:BTSG - Get Free Report) last announced its earnings results on Friday, May 2nd. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.09 by $0.10. BrightSpring Health Services had a negative net margin of 0.38% and a positive return on equity of 4.16%. The business had revenue of $2.88 billion during the quarter, compared to the consensus estimate of $2.74 billion. During the same quarter last year, the firm earned $0.12 earnings per share. BrightSpring Health Services's quarterly revenue was up 25.9% on a year-over-year basis. On average, analysts anticipate that BrightSpring Health Services, Inc. will post 0.59 EPS for the current year.

About BrightSpring Health Services

BrightSpring Health Services, Inc operates a home and community-based healthcare services platform in the United States. The company's platform focuses on delivering pharmacy and provider services, including clinical and supportive care in home and community settings to Medicare, Medicaid, and insured populations.